WA
GSK icon

WPG Advisers’s GSK GSK Stock Holding History

WPG Advisers’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.99K Hold
57
– – ﹤0.01% 1094
2026
Q1 		$3.15K Sell
57
-16
-22% -$867 ﹤0.01% 989
2025
Q4 		$3.58K Sell
73
-181
-71% -$8.44K ﹤0.01% 990
2025
Q3 		$11K Sell
254
-101
-28% -$3.94K 0.01% 668
2025
Q2 		$13.6K Sell
355
-15
-4% -$573 0.01% 578
2025
Q1 		$14.3K Sell
370
-236
-39% -$8.64K 0.01% 552
2024
Q4 		$20.5K Buy
+606
New +$21.8K 0.02% 456

Other funds holding GSK

Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
JEST
JTC Employer Solutions Trustee St Helier, Jersey $1.25B AUM 41.83% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
MIP
Mondrian Investment Partners London, United Kingdom $6.48B AUM 18.36% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
EIC
Equity Investment Corp Atlanta, Georgia $5.24B AUM 11.32% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return
MHI
Miller Howard Investments Kingston, New York $3.77B AUM 23.82% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return
DLA
Douglas Lane & Associates New York $7.37B AUM 21.9% 1-Year Est. Return

WPG Advisers's GSK Position: Q2 2026 in Review

WPG Advisers held its GSK (GSK) position steady in Q2 2026 at 57 shares worth $2.99K. The position accounts for ﹤0.01% of the portfolio, ranked #1094.

WPG Advisers first reported a position in GSK in Q4 2024 and has held it in 7 quarters since. The position peaked at $20.5K in Q4 2024. 627 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

  • WPG Advisers held 57 shares of GSK worth $2.99K as of Q2 2026.
  • WPG Advisers left its GSK share count unchanged in Q2 2026.
  • GSK made up ﹤0.01% of WPG Advisers's portfolio in Q2 2026, its #1094 holding.
  • WPG Advisers first reported a position in GSK in Q4 2024 and has held it in 7 quarters since.
  • WPG Advisers's GSK position peaked at $20.5K in Q4 2024.
  • 627 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on WPG Advisers's 13F filing for Q2 2026, filed 6 Aug 2026.